Log in
Enquire now
‌

US Patent D782037 Steerable guiding catheter handle

Patent D782037 was granted and assigned to Oscor Inc. on March, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Oscor Inc.
Oscor Inc.
Current Assignee
Oscor Inc.
Oscor Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
D782037
Patent Inventor Names
Michael J. Gelineau0
Thomas P. Osypka0
Date of Patent
March 21, 2017
Patent Application Number
29498851
Date Filed
August 8, 2014
Patent Citations Received
‌
US Patent 12121307 Vision-based position and orientation determination for endovascular tools
0
‌
US Patent 11759614 Enhanced stylet for drug depot injector
‌
US Patent 11779406 Systems and methods for guidance of intraluminal devices within the vasculature
‌
US Patent 12017050 Drug depot delivery system and method
0
‌
US Patent D1039703 Patient user interface
0
‌
US Patent 12076519 Drug delivery device and methods having a retaining member
0
‌
US Patent 11707332 Image space control for endovascular tools
0
‌
US Patent D998791 Syringe adapter
Patent Primary Examiner
‌
David Muller
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent D782037 Steerable guiding catheter handle

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.